Skip to content
Brand AI

Arsenal Biosciences

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Teneobio and ArsenalBio enter research collaboration and license agreement

    Teneobio announced that it had entered a research collaboration and commercial license agreement with ArsenalBio for the use of Teneobio's UniDabs in CAR T-cell therapy. ArsenalBio will have commercial rights to UniDabs against therapy-guiding antigens for one of its proprietary immune cell therapy programs.

    Source